Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma And Psychedelic Medicine: Eli Lilly's $3.8 Billion Bet
Human brain developing into extraordinary due to use of natural medicine On July 16, 2026, Eli Lilly announced it would acquire AtaiBeckley for up to $3.8 billion — $2.8 billion up front, with another $1 billion in milestone-linked…
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Korean firm bids CHF1.5bn for Swiss pharma supplier Polypeptide
The company is offering CHF44.31 per share in cash, valuing Polypeptide at around CHF1.5 billion. Polypeptide's board of directors supports the offer, both companies announced on Monday. The major shareholder, Draupnir Holding, which holds just…
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
The iShares Global Healthcare ETF (IXJ 0.56%) provides broad global sector exposure, while VanEck Pharmaceutical ETF (PPH 0.72%) offers a more concentrated, higher-yielding approach specifically focused on pharmaceutical companies. These funds both…
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
Invesco Pharmaceuticals ETF (PJP 0.30%) offers concentrated U.S. pharma exposure, while iShares Global Healthcare ETF (IXJ 0.56%) provides a more diversified, lower-cost global approach with higher assets under management and dividend yields.
Bristol Partners With Nvidia on AI Factory for Drug Development
Bristol Myers Squibb Co. is expanding its partnership with Nvidia Corp. to boost the computing power of an AI factory that the drugmaker say it's using to create new medicines more quickly. The tie-up is one of several between the chipmaker and…
Private banks drag indices lower; PSU banks, pharma cushion losses
Markets closed lower on Monday as disappointing net interest margins from a key private-sector lender and renewed geopolitical tensions in the Middle East kept investors cautious throughout the session, even as public-sector banks and pharma stocks…
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 5.6% - Time to Sell?
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report)'s share price was down 5.6% on Monday. The stock traded as low as $30.06 and last traded at $29.9130. Approximately 698,804 shares changed hands during mid-day trading, a decline of…
Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)
The board of JSW Steel Ltd has approved the company's participation in the proposed IPO of JSW One Platforms Ltd (JOPL) as a promoter selling shareholder. The company plans to sell equity shares worth up to ₹811 crore through an offer for…
NervGen Pharma (NASDAQ:NGEN) Upgraded by Wall Street Zen to 'Hold' Rating
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research note issued on Monday. A number of other brokerages have also recently weighed in on NGEN.
Hsbc Holdings PLC Acquires 1,486,020 Shares of Royalty Pharma PLC $RPRX
Hsbc Holdings PLC lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 2,562.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,544,018 shares of…
OKYO Pharma (NASDAQ:OKYO) Posts Earnings Results, Misses Estimates By $5.45 EPS
OKYO Pharma (NASDAQ:OKYO - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($5.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($5.45), FiscalAI reports.
Fifth Third Bancorp Purchases Shares of 49,729 BridgeBio Pharma, Inc. $BBIO
Fifth Third Bancorp purchased a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund…
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Receives Average Rating of 'Hold' from Brokerages
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have been assigned an average recommendation of 'Hold' from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst…
Jennison Associates LLC Cuts Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Jennison Associates LLC cut its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 21.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned…
Receive a Daily briefing on Pharma Industry News
Get Started